Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Tonix Pharmaceuticals Stock (NASDAQ: TNXP) stock price, news, charts, stock research, profile.

Open	$0.56
Close	$0.61
Volume / Avg.	293.22M / 85.57M
Day Range	$0.53 - $0.70
52 Wk Range	0.12 - 22.14
Market Cap	$96.34M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	0.85%
Days to Cover	1

Recent News

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Tonix Pharmaceuticals Stock Today?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for TNX-102 SL, a 5.6 mg non-opioid. Here's what you need to know.

Vaishali Prayag

Crude Oil Down Over 1%; US Industrial Production Declines In November

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.56
Close	$0.61
Volume / Avg.	293.22M / 85.57M
Day Range	$0.53 - $0.70
52 Wk Range	0.12 - 22.14
Market Cap	$96.34M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	0.85%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tonix Pharmaceuticals (TNXP) stock?

You can purchase shares of Tonix Pharmaceuticals (NASDAQ:TNXP) through any online brokerage.

View our list of the best stock brokerages

Who are Tonix Pharmaceuticals (TNXP) competitors?

Other companies in Tonix Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), INmune Bio (NASDAQ:INMB), Lineage Cell Therapeutics (AMEX:LCTX) and Assembly Biosciences (NASDAQ:ASMB).

What is the forecast, or price target, for Tonix Pharmaceuticals (TNXP) stock?

Tonix Pharmaceuticals has a consensus price target of $4.87.

What is the current price for Tonix Pharmaceuticals (TNXP)?

The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $0.5155 last updated December 20, 2024 at 7:59 PM EST.

Does Tonix Pharmaceuticals (TNXP) pay a dividend?

There are no upcoming dividends for Tonix Pharmaceuticals.

When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?

Tonix Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Tonix Pharmaceuticals (TNXP) going to split?

There is no upcoming split for Tonix Pharmaceuticals.

What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Tonix Pharmaceuticals

Tonix Pharmaceuticals (TNXP) Forecast